Inhibition of miR-19 down-regulates multidrug resistance genes (MDR-1, MRP-1 and BCRP) and restores PTEN expression in MDR breast cancer cells, sensitizing cells to chemotherapeutic agents [134]. Here, PTEN is linked to breast carcinoma.